Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amethocaine versus EMLA for intravenous cannulation in children
ACTRN12606000409572Phase 4Not yet recruiting
- Sponsor
- Auckland District Health Board
- Start
- Nov 2006
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of tetracaine and lidocaine + prilocaine (2 arms), sponsored by Auckland District Health Board. Primary endpoint: First attempt cannulation success. Planned start Nov 2006; status: not yet recruiting.
02
Drugs
tetracainelidocaine + prilocaine
Beyond the preview
Go deeper on ACTRN12606000409572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000409572.